The company expanded to the US last year and Sleepio has now been deployed to over 750.000 employees at companies, among which are Linkedin and Comcast. The latest funding round was led by the London-based capital firm Octopus Ventures, which also invested in healthy snack start up Graze and gym chain GymBox.
Other investors are – amongst others – Kaiser Permanente Ventures, Index Ventures, Sean Duffy (CEO of Omada Health), and JamJar Investments, the British investment fund of the Innocent drinks. They join the current investors Esther Dyson and former Google Ventures partner Peter Read.
“This new investment gives us the possibility to reach our goal to help millions be menally healtier, by increasing the number of corporations we work with and to further develop our products. Doing so, we can help address an ever-wider range of mental health issues”, so says Peter Hames, CEO of Big Health.
"But we’ll only achieve this goal — and firmly establish a new ‘digital medicine’ industry — by remaining committed to evidence-based solutions that deliver real outcomes for users."
The company has published 14 academic papers and claims that her products are based on groundbreaking scientific research. Professor Colin Espie, co-founder and Chief Medical Officer of Big Health: "We openly encourage independent investigators to evaluate our products and publish their findings. We believe an ethical approach to creating health solutions should be a critical value, not an inconvenience."